Malawi vs South-East Asia (WHO region): HIV-positive TB patients on ART (antiretroviral therapy)

Malawi
100.0%
in 2024
South-East Asia (WHO region)
94.0%
in 2024
Malawi rank
1st
South-East Asia (WHO region) rank
4th

HIV-positive TB patients on ART (antiretroviral therapy) over time

  • Malawi
  • South-East Asia (WHO region)
020406080100200320132024

How they compare

Malawi currently reports 100.0% against 94.0% in South-East Asia (WHO region), a difference of 6.0%.

That makes Malawi's figure about 1.1 times South-East Asia (WHO region)'s.

The two have swapped places 3 times across 21 shared years of data; in 2003 it was South-East Asia (WHO region) ahead.

Malawi ranks 1st and South-East Asia (WHO region) ranks 4th of 144 countries.

Malawi has averaged higher in every one of the 3 decades both report.

Head to head by decade

Decade Malawi South-East Asia (WHO region) Difference Ahead
2000s 35.3% 34.1% 1.2% Malawi
2010s 85.5% 76.0% 9.5% Malawi
2020s 99.4% 92.2% 7.2% Malawi

Averages of every year both report within each decade.

Frequently asked questions

Which has higher hiv-positive tb patients on art (antiretroviral therapy), Malawi or South-East Asia (WHO region)?
Malawi, at 100.0% against 94.0% in South-East Asia (WHO region) as of 2024.
What is the difference in hiv-positive tb patients on art (antiretroviral therapy) between Malawi and South-East Asia (WHO region)?
6.0%, with Malawi ahead.
How many years of comparable data are there for Malawi and South-East Asia (WHO region)?
21 years are reported by both, from 2003 to 2024.
How do Malawi and South-East Asia (WHO region) rank globally for hiv-positive tb patients on art (antiretroviral therapy)?
Malawi ranks 1st and South-East Asia (WHO region) ranks 4th of 144 countries.
Where does this data come from?
World Health Organization, Global Health Observatory, published as HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.

Individual pages

Share, cite or embed this page

Cite this page

Malawi vs South-East Asia (WHO region): HIV-positive TB patients on ART (antiretroviral therapy). Statizoid, drawing on World Health Organization, Global Health Observatory. Retrieved 18 September 2026, from https://health.statizoid.com/compare/hiv-positive-tb-patients-on-art-antiretroviral-therapy-percent/malawi/south-east-asia-who-region/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY-NC-SA 3.0 IGO (WHO); please keep the attribution.

<a href="https://health.statizoid.com/compare/hiv-positive-tb-patients-on-art-antiretroviral-therapy-percent/malawi/south-east-asia-who-region/">Malawi vs South-East Asia (WHO region): HIV-positive TB patients on ART (antiretroviral therapy)</a> — Statizoid

About this data

Indicator
HIV-positive TB patients on ART (antiretroviral therapy) (%)
Source
World Health Organization, Global Health Observatory
Licence
CC BY-NC-SA 3.0 IGO (WHO)
Coverage
157 places, 2,569 data points, 2003–2024
Last refreshed